Patent Assignment
Reel/Frame 043211/0502
Certificate of Amalgamation
Recorded: 2017-07-17
Pages: 3
Assignor
AFEXA LIFE SCIENCES INC.
Executed: 2012-01-01
Assignee
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
2150 ST. ELZEAR BLVD. WEST, LAVAL, H7L 4A8, CANADA
Covered Property
(1)
Synergistic Pharmaceutical Composition, Method of Making Same and Use of Same
Related Assignments
(16)
Other recorded transfers of the patent in this record — the chain of ownership.
Redacted Asset Transfer Agreement
Jul 17, 2017
From: VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
To: VALEANT CANADA LP
Reel/Frame 043211/0575 →
Security Interest
Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 045444/0634 →
Security Interest
Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 045444/0299 →
Intellectual Property Security Agreement
Jul 3, 2019
From: BAUSCH HEALTH IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 049672/0652 →
Security Interest
Oct 5, 2021
From: BAUSCH & LOMB IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; DR. GERHARD MANN CHEM.-PHARM. FABRIK GMBH; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 057821/0800 →
Security Interest
Jun 13, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON
Reel/Frame 060346/0705 →
Assignment of Assignor's Interest
Jan 13, 2023
From: BAUSCH HEALTH, CANADA INC.
To: BAUSCH + LOMB CORPORATION
Reel/Frame 062374/0174 →
Assignment of Assignor's Interest
Jan 13, 2023
From: VALEANT CANADA LP
To: BAUSCH HEALTH, CANADA INC.
Reel/Frame 062373/0488 →
Omnibus Patent Security Release Agreement (Reel/Frame 057821/0800)
Apr 17, 2024
From: THE BANK OF NEW YORK MELLON
To: BAUSCH + LOMB IRELAND LIMITED; BAUSCH + LOMB CORPORATION
Reel/Frame 067131/0651 →
Omnibus Patent Security Release Agreement (Reel/Frame 060346/0705)
Apr 17, 2024
From: THE BANK OF NEW YORK MELLON
To: BAUSCH + LOMB CORPORATION
Reel/Frame 067131/0673 →
Omnibus Patent Security Release Agreement (Reel/Frame 049672/0652)
Apr 17, 2024
From: THE BANK OF NEW YORK MELLON
To: BAUSCH + LOMB IRELAND LIMITED; BAUSCH + LOMB CORPORATION
Reel/Frame 067131/0618 →
Omnibus Patent Security Release Agreement (Reel/Frame 045444/0634)
Apr 17, 2024
From: THE BANK OF NEW YORK MELLON
To: BAUSCH + LOMB IRELAND LIMITED; BAUSCH + LOMB CORPORATION
Reel/Frame 067131/0596 →
Release of Security Interest in Specified Patents (Reel/Frame 045444/0299)
Apr 17, 2024
From: BARCLAYS BANK PLC
To: BAUSCH + LOMB IRELAND LIMITED; BAUSCH + LOMB CORPORATION
Reel/Frame 067131/0587 →
Release of Security Interest
Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
Reel/Frame 073637/0001 →
Release of Security Interest
Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; TECHNOLAS PERFECT VISION GMBH
Reel/Frame 073637/0222 →
Release of Security Interest
Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
Reel/Frame 073654/0300 →